CANCER GENETICS INC - COM (CGIX)

CUSIP: 13739U104

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
2,535,633
Share change
+376,721
Total reported value
$10,396,000
Price per share
$4.10
Number of holders
31
Value change
+$1,931,174
Number of buys
20
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 13739U104?
CUSIP 13739U104 identifies CGIX - CANCER GENETICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CANCER GENETICS INC - COM (CGIX) as of Q1 2017

As of 31 Mar 2017, CANCER GENETICS INC - COM (CGIX) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,535,633 shares. The largest 10 holders included PERKINS CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Fairbanks Capital Management, Inc., EAM Investors, LLC, WEDBUSH SECURITIES INC, GEODE CAPITAL MANAGEMENT, LLC, DIKER MANAGEMENT LLC, PANAGORA ASSET MANAGEMENT INC, and BlackRock Inc.. This page lists 31 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.